| Name: | (1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one (Mirogabalin Besylate Intermediate) | 
|---|---|
| CAS:: | 1235479-61-4 | 
| Chiral purity: | NLT 99.0 | 
| Purity: | NLT 99.0 | 
| Standard: | In-house | 
| Documentation: | CMC | 
| Development stage: | Commercialization | 
Mirogabalin Besylate Intermediate
Mirogabalin (brand name Tarlige; developmental code name DS-5565) is a medication developed by Daiichi Sankyo, a gabapentinoid. Gabapentin and pregabalin are also members of this class. As a gabapentinoid, mirogabalin binds to the α2δ subunit of voltage-gated calcium channel (1 and 2), but with significantly higher potency than pregabalin.